INTEGRATED SYSTEMS ENGINEERING SRL

Their core work

ISENET is an Italian engineering SME that designs and builds automated systems for biomedical and pathology laboratory applications. Their core product work centers on automating Tissue Microarray (TMA) instruments — equipment used in hospitals and research labs to prepare and analyze hundreds of tissue samples simultaneously. Beyond their own product line, they contribute precision systems integration and automation engineering to larger biomedical research consortia, as seen in their participation in a project combining stem cell biology with silk-fibroin bio-interfaces. They occupy a niche at the intersection of mechanical/electronic engineering and clinical diagnostics technology.

What they specialise in

How they've shifted over time

ISENET entered H2020 in 2016 with a clear commercial goal: assess the market for their own automated TMA product via an SME Instrument feasibility study. A year later they shifted toward contributing their engineering capabilities into a frontier biomedical research project (SilkFUSION), which ran until 2022 under the Research Excellence pillar. The trajectory suggests a move from product-focused market validation toward deeper integration with academic research teams — possibly to gain scientific credibility or access to advanced biological platforms that could expand their product scope.

ISENET appears to be bridging from commercial diagnostics automation into fundamental biomedical research infrastructure, which positions them as a potential engineering partner for biotech and medtech consortia seeking hardware integration expertise.

How they like to work

ISENET has experience on both sides of project leadership: they coordinated Prometeo independently as an SME, and joined a larger RIA consortium as a partner in SilkFUSION. With only 5 known consortium partners across 2 projects, their network is small and their collaborations have been selective rather than broad. This suggests they work best in tight, technically focused teams where their specific automation expertise is a clear, defined contribution rather than a peripheral one.

ISENET has worked with 5 unique partners spread across 5 countries, indicating a genuinely European (though compact) collaboration network. No partner repetition is visible across their two projects, suggesting their network is still forming rather than consolidated.

What sets them apart

ISENET fills a rare niche: an SME that combines hands-on engineering automation capability with demonstrated participation in frontier biomedical research — something most pure engineering firms lack. Their Prometeo work on TMA systems is highly specialized; few European SMEs have built automation specifically for pathology tissue analysis workflows. For a consortium that needs an engineering partner who understands biomedical laboratory environments from a systems integration standpoint, ISENET offers direct product experience rather than purely academic competence.

Highlights from their portfolio

• Prometeo
  ISENET's only coordinator role — a focused SME Instrument feasibility study for automating tissue microarray systems, revealing a proprietary product under development for the pathology diagnostics market.
• SilkFUSION
  Their largest funded project (€319K) placed them inside a cutting-edge Research Excellence consortium combining stem cell engineering with silk-fibroin bio-interfaces, well outside typical engineering SME territory.